Document:

INSIDER
        PLEDGE AND ESCROW AGREEMENT

       

      THIS
        INSIDER PLEDGE AND ESCROW AGREEMENT
        (the
“Agreement”)
        is
        made and entered into as of April 1, 2006 (the “Effective
        Date”)
        by and
        among RAINIER
        GONZALEZ
        (the
“Pledgor”),
        CORNELL
        CAPITAL PARTNERS, LP
        (the
“Pledgee”),
        PACER
        HEALTH CORPORATION,
        a
        Florida corporation (the “Company”),
        and
DAVID
        GONZALEZ,
        ESQ.,
        as
        escrow agent (“Escrow
        Agent”).
        

       

      RECITALS:

       

      WHEREAS,
        the
        Company shall issue and sell to the Pledgee, as provided in the Securities
        Purchase Agreement of even date herewith between the Company and the Pledgee
        (the “Securities
        Purchase Agreement”),
        and
        the Pledgee shall purchase up to Two Million Dollars ($2,000,000) of secured
        convertible debentures (the “Convertible
        Debentures”),
        which
        shall be convertible into shares of the Company’s common stock, par value
        $0.0001 per share (the “Common
        Stock”)
        (as
        converted, the “Conversion
        Shares”);
        and

       

      WHEREAS,
        to
        induce
        the Pledgee to enter into the transaction contemplated by the Securities
        Purchase Agreement, the Convertible Debentures, the Investor Registration
        Rights
        Agreement of even date herewith between the Company and the Pledgee (the
        “Investor
        Registration Rights Agreement”)
        and
        the Irrevocable Transfer Agent Instructions among the Company, the Pledgee,
        the
        Transfer Agent, and the Escrow Agent (the “Transfer
        Agent Instructions”)
        (collectively referred to as the “Transaction
        Documents”),
        the
        Pledgor has agreed to irrevocably pledge to the Pledgee Four Hundred Thirty
        Million
        Four Hundred Twenty Two Thousand Nine Hundred Three (430,422,903) shares
        (the “Pledged
        Shares”)
        of
        Common Stock beneficially owned by the Pledgor in accordance with this
        Agreement.

       

      NOW,
        THEREFORE,
        for and
        in consideration of the mutual covenants, agreements, warranties, and
        representations herein contained, and for other good and valuable consideration,
        the receipt and sufficiency of which is hereby acknowledged, the parties
        hereto
        agree as follows:

       

       

      TERMS
        AND CONDITIONS

       

      1.  Obligations
        Secured.The
        obligations secured hereby are any and all obligations of the Company now
        existing or hereinafter incurred to the Pledgee, whether oral or written
        and
        whether arising before, on or after the date hereof including, without
        limitation, those obligations of the Company to the Pledgee under the
        Transaction Documents and any other amounts now or hereafter owed to the
        Pledgee
        by the Company thereunder (collectively, the “Obligations”).

       

      2.  Pledge
        and Transfer of Pledged Shares.
        The
        Pledgor hereby grants to Pledgee an irrevocable, first priority security
        interest in all Pledged Shares as security for the Company’s Obligations.
        Simultaneously with the execution of the Transaction Documents, the Pledgor
        shall deliver to the Escrow Agent stock certificates made out in favor of
        the
        Pledgor representing the Pledged Shares, together with duly executed stock
        powers or other appropriate transfer documents with medallion bank guarantees
        and executed in blank by the Pledgor (the “Transfer
        Documents”),
        and
        such stock certificates and Transfer Documents shall be held by the Escrow
        Agent
        until the full payment of all Obligations due to the Pledgee, including the
        repayment of all amounts owed by the Company to the Pledgee under the
        Convertible Debentures (whether outstanding principal, interest, legal fees,
        or
        any other amounts owed to the Pledgee by the Company).

       

       

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

       

       

      3.  Rights
        Relating to Pledged Shares.
        Upon
        the occurrence of an Event of Default (as defined herein), the Pledgee shall
        be
        entitled to vote the Pledged Shares, receive dividends and other distributions
        thereon, and enjoy all other rights and privileges incident to the ownership
        of
        the number of Pledged Shares actually released from escrow in accordance
        with
        Section 6.1 hereof. 

       

      4.  Release
        of Pledged Shares from Pledge.
        Upon
        the full payment of all Obligations due to the Pledgee under the Transaction
        Documents, including the repayment of all amounts owed by the Company to
        the
        Pledgee under the Convertible Debentures (whether outstanding principal,
        interest, legal fees, and any other amounts owed to the Pledgee by the Company),
        the parties hereto shall notify the Escrow Agent to such effect in writing.
        Promptly upon receipt of such written notice, the Escrow Agent shall return
        to
        the Pledgor the Transfer Documents and the certificates representing the
        Pledged
        Shares (collectively the “Pledged
        Materials”),
        whereupon any and all rights of Pledgee in the Pledged Materials shall be
        terminated.

       

      5.  Event
        of Default.
        An
“Event
        of Default”
shall
        be deemed to have occurred under this Agreement upon an Event of Default
        under
        the Convertible Debentures.

       

      6.  Remedies.
        

       

      a.  Upon
        and
        anytime after the occurrence of an Event of Default, the Pledgee shall have
        the
        right to provide written notice of such Event of Default (the “Default
        Notice”)
        to the Escrow Agent, with a copy to the Pledgor. As soon as practicable after
        receipt of the Default Notice, the Escrow Agent shall deliver to Pledgee
        the
        Pledged Materials held by the Escrow Agent hereunder. Upon receipt of the
        Pledged Materials, the Pledgee shall have the right to (i) sell the Pledged
        Shares and to apply the proceeds of such sales, net of any selling commissions,
        to the Obligations owed to the Pledgor by the Company under the Transaction
        Documents, including, without limitation, outstanding principal, interest,
        legal
        fees, and any other amounts owed to the Pledgee, and exercise all other rights
        and (ii) any and all remedies of a secured party with respect to such property
        as may be available under the Uniform Commercial Code as in effect in the
        State
        of New Jersey. To the extent that the net proceeds received by the Pledgee
        are
        insufficient to satisfy the Obligations in full, the Pledgee shall be entitled
        to a deficiency judgment against the Pledgor or the Company for such amount.
        The
        Pledgee shall have the absolute right to sell or dispose of the Pledged Shares
        in any manner it sees fit and shall have no liability to the Pledgor, the
        Company or any other party for selling or disposing of such Pledged Shares
        even
        if other methods of sales or dispositions would or allegedly would result
        in
        greater proceeds than the method actually used. The Escrow Agent shall have
        the
        absolute right to disburse the Pledged Shares to the Pledgee in batches not
        to
        exceed 9.9% of the outstanding capital of the Company (which limit may be
        waived
        by the Pledgee providing not less than 65 days’ prior written notice to the
        Escrow Agent). The Pledgee shall return any Pledged Shares released to it
        and
        remaining after the Pledgee has applied the net proceeds to all amounts owed
        to
        the Pledgee. 

       

       

      
        
          
          

        

        
          2

          
            

          

        

        
          
          

        

      

       

       

      b.  Each
        right, power and remedy of the Pledgee provided for in this Agreement or
        any
        other Transaction Document shall be cumulative and concurrent and shall be
        in
        addition to every other such right, power or remedy. The
        exercise or beginning of the exercise by the Pledgee of any one or more of
        the
        rights, powers or remedies provided for in this Agreement or any
        other
        Transaction Document or
        now or
        hereafter existing at law or in equity or by statute or otherwise shall not
        preclude the simultaneous or later exercise by the
        Pledgee of all such other rights, powers or remedies, and no failure or delay
        on
        the part of the Pledgee to exercise any such right, power or remedy shall
        operate as a waiver thereof. No notice to or demand on the Pledgor in any
        case
        shall entitle it to any other or further notice or demand in similar or other
        circumstances or constitute a waiver of any of the rights of the Pledgee
        to any
        other further action in any circumstances without demand or notice. The Pledgee
        shall have the full power to enforce or to assign or contract is rights under
        this Agreement to a third party. 

       

      7.  Representations,
        Warranties and Covenants.
        

       

                 a.  The
        Pledgor represents, warrants and covenants that:

       

      (i)  Pledgor
        is, and at the time when pledged hereunder will be, the legal, beneficial
        and
        record owner of, and has (and will have)
        good and
        valid title to, all Pledged Shares pledged hereunder, subject to no pledge,
        lien, mortgage, hypothecation, security interest, charge, option or other
        encumbrance whatsoever;

       

      (ii)  Pledgor
        has full power, authority and legal right to pledge all the Pledged Shares
        pledged pursuant to this Agreement; and

       

      (iii)  all
        the
        Pledged Shares have been duly and validly issued, are fully paid and
        non-assessable and are subject to no options to purchase or similar
        rights.

       

      b.  The
        Pledgor covenants and agrees to take all reasonable steps to defend the
        Pledgee’s right, title and security interest in and to the Pledged Shares and
        the proceeds thereof against the claims and demands of all persons whomsoever
        (other than the Pledgee and the Escrow Agent); and the Pledgor covenants
        and
        agrees that it will have like title to
        and
        right to pledge any other property at any time hereafter pledged to the Pledgee
        as Collateral hereunder and will likewise take all reasonable steps to defend
        the right thereto and security interest therein of the Pledgee.

       

      c.  The
        Pledgor covenants and agrees to take no action which would violate or be
        inconsistent with any of the terms of any Transaction Document, or which
        would
        have the effect of impairing the position or interests of the Pledgee under
        any
        Transaction Document.

       

      d.  The
        Pledgor represents, warrants and covenants that (i) the Pledgor has been
        the
        beneficial owner of the Pledged Shares for a period of not less than two
        (2)
        years as computed in accordance with Rule 144(d) promulgated under the
        Securities Act of 1933, as amended, and (ii) this Agreement is made with
        recourse. Upon an Event of Default, the Pledgee shall be deemed to have acquired
        the Pledged Shares on the date they were acquired by the Pledgor. The Pledgor
        is
        an “affiliate” of the Company, as such term is defined in Rule 144(a)
        promulgated under the Securities Act of 1933, as amended.

       

       

      
        
          
          

        

        
          3

          
            

          

        

        
          
          

        

      

       

       

      8.  Concerning
        the Escrow Agent.

       

      a.  The
        Escrow Agent undertakes to perform only such duties as are expressly set
        forth
        herein and no implied duties or obligations shall be read into this Agreement
        against the Escrow Agent.

       

      b.  The
        Escrow Agent may act in reliance upon any writing or instrument or signature
        which it, in good faith, believes to be genuine, may assume the validity
        and
        accuracy of any statement or assertion contained in such a writing or
        instrument, and may assume that any person purporting to give any writing,
        notice, advice or instructions in connection with the provisions hereof has
        been
        duly authorized to do so. The Escrow Agent shall not be liable in any manner
        for
        the sufficiency or correctness as to form, manner, and execution, or validity
        of
        any instrument deposited in this escrow, nor as to the identity, authority,
        or
        right of any person executing the same; and its duties hereunder shall be
        limited to the safekeeping of such certificates, monies, instruments, or
        other
        document received by it as such escrow holder, and for the disposition of
        the
        same in accordance with the written instruments accepted by it in the
        escrow.

       

      c.  Pledgee
        and the Pledgor hereby agree, to defend and indemnify the Escrow Agent and
        hold
        it harmless from any and all claims, liabilities, losses, actions, suits,
        or
        proceedings at law or in equity, or any other expenses, fees, or charges
        of any
        character or nature which it may incur or with which it may be threatened
        by
        reason of its acting as Escrow Agent under this Agreement; and in connection
        therewith, to indemnify the Escrow Agent against any and all expenses, including
        attorneys’ fees and costs of defending any action, suit, or proceeding or
        resisting any claim (and any costs incurred by the Escrow Agent pursuant
        to
        Sections 6.4 or 6.5 hereof). The Escrow Agent shall be vested with a lien
        on all
        property deposited hereunder, for indemnification of attorneys’ fees and court
        costs regarding any suit, proceeding or otherwise, or any other expenses,
        fees,
        or charges of any character or nature, which may be incurred by the Escrow
        Agent
        by reason of disputes arising between the makers of this escrow as to the
        correct interpretation of this Agreement and instructions given to the Escrow
        Agent hereunder, or otherwise, with the right of the Escrow Agent, regardless
        of
        the instructions aforesaid, to hold said property until and unless said
        additional expenses, fees, and charges shall be fully paid. Any fees and
        costs
        charged by the Escrow Agent for serving hereunder shall be paid by the
        Pledgor.

       

      d.  If
        any of
        the parties shall be in disagreement about the interpretation of this Agreement,
        or about the rights and obligations, or the propriety of any action contemplated
        by the Escrow Agent hereunder, the Escrow Agent may, at its sole discretion
        deposit the Pledged Materials with the Clerk of the United States District
        Court
        of New Jersey, sitting in Newark, New Jersey, and, upon notifying all parties
        concerned of such action, all liability on the part of the Escrow Agent shall
        fully cease and terminate. The Escrow Agent shall be indemnified by the Pledgor,
        the Company and Pledgee for all costs, including reasonable attorneys’ fees in
        connection with the aforesaid proceeding, and shall be fully protected in
        suspending all or a part of its activities under this Agreement until a final
        decision or other settlement in the proceeding is received.

       

       

      
        
          
          

        

        
          4

          
            

          

        

        
          
          

        

      

       

       

      e.  The
        Escrow Agent may consult with counsel of its own choice (and the costs of
        such
        counsel shall be paid by the Pledgor and Pledgee) and shall have full and
        complete authorization and protection for any action taken or suffered by
        it
        hereunder in good faith and in accordance with the opinion of such counsel.
        The
        Escrow Agent shall not be liable for any mistakes of fact or error of judgment,
        or for any actions or omissions of any kind, unless caused by its willful
        misconduct or gross negligence.

       

      f.  The
        Escrow Agent may resign upon ten (10) days’ written notice to the parties in
        this Agreement. If a successor Escrow Agent is not appointed within this
        ten
        (10) day period, the Escrow Agent may petition a court of competent jurisdiction
        to name a successor.

       

      9.  Conflict
        Waiver.
        The
        Pledgor hereby acknowledges that the Escrow Agent is general counsel to the
        Pledgee, a partner in the general partner of the Pledgee, and counsel to
        the
        Pledgee in connection with the transactions contemplated and referred herein.
        The Pledgor agrees that in the event of any dispute arising in connection
        with
        this Agreement or otherwise in connection with any transaction or agreement
        contemplated and referred herein, the Escrow Agent shall be permitted to
        continue to represent the Pledgee and the Pledgor will not seek to disqualify
        such counsel and waives any objection Pledgor might have with respect to
        the
        Escrow Agent acting as the Escrow Agent pursuant to this Agreement.

       

      10.  Notices.
        Unless
        otherwise provided herein, all demands, notices, consents, service of process,
        requests and other communications hereunder shall be in writing and shall
        be
        delivered in person or by overnight courier service, or mailed by certified
        mail, return receipt requested, addressed:

      
        

        
          	
                  If
                    to the Company, to:

                	
                  Pacer
                    Health Corporation

                
	 	
                  7759
                    N.W. 146th
                    Street

                
	 	
                  Miami
                    Lakes, Florida 33016

                
	 	
                  Attention:

                	
                  Rainier
                    Gonzalez

                
	 	
                  Telephone:

                	
                  (305)
                    828-7660

                
	 	
                  Facsimile:

                	
                  (305)
                    282-2551

                
	 	 
	
                  With
                    a copy to:

                	
                  Kirkpatrick
                    & Lockhart Nicholson Graham, LLP

                
	 	
                  201
                    South Biscayne Boulevard, Suite 2000

                
	 	
                  Miami,
                    Florida 33131

                
	 	
                  Attention:

                	
                  Clayton
                    E. Parker, Esq.

                
	 	
                  Telephone:

                	
                  (305)
                    539-3306

                
	 	
                  Facsimile:

                	
                  (305)
                    328-7095

                
	 	 
	
                  If
                    to the Pledgee:

                	
                  Cornell
                    Capital Partners LP

                
	 	
                  101
                    Hudson Street, Suite 3700

                
	 	
                  Jersey
                    City, NJ 07302

                
	 	
                  Attention:

                	
                  Mark
                    A. Angelo

                
	 	
                  Telephone:

                	
                  (201)
                    985-8300

                
	 	
                  Facsimile:

                	
                  (201)
                    985-8744

                
	 	 

        

         

         

        
          
            
            

          

          
            5

            
              

            

          

          
            
            

          

        

         

         

        
          	
                  With
                    copy to:

                	
                  Cornell
                    Capital Partners, LP

                
	 	
                  101
                    Hudson Street, Suite 3700

                
	 	
                  Jersey
                    City, NJ 07302

                
	 	
                  Attention:

                	
                  David
                    Gonzalez, Esq.

                
	 	
                  Telephone:

                	
                  (201)
                    985-8300

                
	 	
                  Facsimile:

                	
                  (201)
                    985-1964

                
	 	 
	
                  If
                    to the Pledgor, to:

                	
                  Rainier
                    Gonzalez

                
	 	
                  7759
                    N.W. 146th
                    Street

                
	 	
                  Miami
                    Lakes, Fl 33016

                
	 	
                  Telephone:

                	
                  (305)
                    828-7660

                
	 	
                  Facsimile:

                	
                  (305)
                    282-2551

                
	 	 

        

        
Any
          such
          notice shall be effective (a) when delivered, if delivered by hand delivery
          or overnight courier service, or (b) five (5) days after deposit in the
          United States mail, as applicable.

      

       

      11.  Binding
        Effect.
        All of
        the covenants and obligations contained herein shall be binding upon and
        shall
        inure to the benefit of the respective parties, their successors and
        assigns.

       

      12.  Governing
        Law; Venue; Service of Process.
        The
        validity, interpretation and performance of this Agreement shall be determined
        in accordance with the laws of the State of New Jersey applicable to contracts
        made and to be performed wholly within that state except to the extent that
        Federal law applies. The parties hereto agree that any disputes, claims,
        disagreements, lawsuits, actions or controversies of any type or nature
        whatsoever that, directly or indirectly, arise from or relate to this Agreement,
        including, without limitation, claims relating to the inducement, construction,
        performance or termination of this Agreement, shall be brought in the state
        superior courts located in Hudson County, New Jersey or Federal district
        courts
        located in Newark, New Jersey, and the parties hereto agree not to challenge
        the
        selection of that venue in any such proceeding for any reason, including,
        without limitation, on the grounds that such venue is an inconvenient forum.
        The
        parties hereto specifically agree that service of process may be made, and
        such
        service of process shall be effective if made, pursuant to Section 8
        hereto.

       

      13.  Enforcement
        Costs.
        If any
        legal action or other pro-ceeding is brought for the enforcement of this
        Agreement, or because of an alleged dispute, breach, default or
        misrepresenta-tion in connection with any provisions of this Agreement, the
        successful or prevailing party or parties shall be entitled to recover
        reasonable attorneys’ fees, court costs and all expenses even if not taxable as
        court costs (including, without limita-tion, all such fees, costs and expenses
        incident to appeals), incurred in that action or proceeding, in addition
        to any
        other relief to which such party or parties may be entitled.

       

      14.  Remedies
        Cumulative.
        No
        remedy herein conferred upon any party is intended to be exclusive of any
        other
        remedy, and each and every such remedy shall be cumulative and shall be in
        addition to every other remedy given hereunder or now or here-after existing
        at
        law, in equity, by statute, or otherwise. No single or partial exercise by
        any
        party of any right, power or remedy hereunder shall preclude any other or
        further exercise thereof. 

       

       

      
        
          
          

        

        
          6

          
            

          

        

        
          
          

        

      

       

       

      15.  Counterparts.
        This
        Agreement may be executed in one or more counterparts, each of which shall
        be
        deemed an original, but all of which together shall constitute the same
        instrument.

       

      16.  No
        Penalties.
        No
        provision of this Agreement is to be interpreted as a penalty upon any party
        to
        this Agreement.

       

      17.  JURY
        TRIAL.
        EACH OF
        THE PLEDGEE AND THE PLEDGOR HEREBY KNOWINGLY, VOLUNTARILY AND INTENTIONALLY
        WAIVES THE RIGHT WHICH IT MAY HAVE TO A TRIAL BY JURY OF ANY CLAIM, DEMAND,
        ACTION OR CAUSE OF ACTION BASED HEREON, OR ARISING OUT OF, UNDER OR IN ANY
        WAY
        CONNECTED WITH THE DEALINGS BETWEEN PLEDGEE AND PLEDGOR, THIS PLEDGE AND
        ESCROW
        AGREEMENT OR ANY DOCUMENT EXECUTED IN CONNECTION HEREWITH, OR ANY COURSE
        OF
        CONDUCT, COURSE OF DEALING, STATEMENTS (WHETHER ORAL OR WRITTEN) OR ACTIONS
        OF
        ANY PARTY HERETO OR THERETO IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER
        ARISING, AND WHETHER IN CONTRACT, TORT, EQUITY OR OTHERWISE. 

       

      [REMAINDER
        OF PAGE INTENTIALLY LEFT BLANK]

       

       

      
        
          
          

        

        
          7

          
            

          

        

        
          
          

        

      

       

       

      IN
        WITNESS WHEREOF,
        the
        parties hereto have duly executed this Insider Pledge and Escrow Agreement
        as of
        the date first above written. 
 

      
        
          	 	 
	 	
                  CORNELL
                    CAPITAL PARTNERS, LP

                
	 	 
	 	
                  By: 
Yorkville
                    Advisors, LLC

                
	 	
                  Its:      
                    General
                    Partner

                
	 	 
	 	
                  By: 

                	
                
	 	
                  Name:  
                    Mark
                    Angelo

                
	 	
                  Title:    
                    Portfolio
                    Manager

                

        

        
          
            
              	 	 
	 	 
	 	
                      PLEDGOR

                    
	 	 
	 	
                      By: 

                    	
                    
	 	
                      Name:  
                        Rainier
                        Gonzalez

                    

            

             

            
              
                
                  	 	 
	 	
                          PACER
                            HEALTH CORPORATION

                        
	 	 
	 	 
	 	
                          By: 

                        	
                        
	 	
                          Name:  
                            Rainier
                            Gonzalez

                        
	 	
                          Title:    
                            CEO

                        

                

                
                  
                    
                      	 	 
	 	 
	 	
                              ESCROW
                                AGENT

                            
	 	 
	 	
                              By: 

                            	
                            
	 	
                              Name:  
                                David
                                Gonzalez, Esq. 

                            

                    

                    
 

                  

                

              

            

          

        

      

      FOR
        VALUE RECEIVED,
        the
        Pledgor hereby unconditionally and absolutely guarantees the Company’s
        Obligations (as defined above). This Agreement is made with
        recourse.

      
 

      
        
          	
                	
                  By:   

                	 	 

        

        
          	 	
                   Name:
                    Rainer Gonzalez

                	 

        

        
 

      

      
        
          
          

        

        
          8WARRANT

     

    THE
      SECURITIES REPRESENTED BY THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE
      SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE
      SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE OFFERED FOR SALE,
      SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION
      STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
      OR
      APPLICABLE STATE SECURITIES LAWS, OR AN OPINION OF COUNSEL IN A FORM REASONABLY
      SATISFACTORY TO THE ISSUER THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT
      OR
      APPLICABLE STATE SECURITIES LAWS OR UNLESS SOLD PURSUANT TO RULE 144 UNDER
      SAID
      ACT. NOTWITHSTANDING THE FOREGOING, THIS WARRANT MAY BE PLEDGED IN CONNECTION
      WITH A BONA FIDE MARGIN ACCOUNT.

     

     

    PACER
      HEALTH CORPORATION

     

    Warrant
      To Purchase Common Stock

     

     

    
      	Warrant No.: CCP-001	
              Number
                of Shares:
                35,000,000

            

    

     

    Date
      of
      Issuance: April 1, 2006

    

    Pacer
      Health Corporation, a Florida corporation (the “Company”),
      hereby certifies that, for good and valuable consideration, the receipt and
      sufficiency of which are hereby acknowledged, Cornell
      Capital Partners, LP
      (the
“Holder”),
      the
      registered holder hereof or its permitted assigns, is entitled, subject to
      the
      terms set forth below, to purchase from the Company upon surrender of this
      Warrant, at any time or times on or after the date hereof, but not after
      11:59 P.M. Eastern Time on the Expiration Date (as defined herein) Thirty
      Five Million (35,000,000) fully paid and nonassessable shares of Common Stock
      (as defined herein) of the Company (the “Warrant
      Shares”)
      at the
      exercise price per share provided in Section 1(b) below or as subsequently
      adjusted; provided, however, that in no event shall the holder be entitled
      to
      exercise this Warrant for a number of Warrant Shares in excess of that number
      of
      Warrant Shares which, upon giving effect to such exercise, would cause the
      aggregate number of shares of Common Stock beneficially owned by the holder
      and
      its affiliates to exceed 4.99% of the outstanding shares of the Common Stock
      following such exercise, except within sixty (60) days of the Expiration Date
      (however, such restriction may be waived by Holder (but only as to itself and
      not to any other holder) upon not less than 65 days prior notice to the
      Company). For purposes of the foregoing proviso, the aggregate number of shares
      of Common Stock beneficially owned by the holder and its affiliates shall
      include the number of shares of Common Stock issuable upon exercise of this
      Warrant with respect to which the determination of such proviso is being made,
      but shall exclude shares of Common Stock which would be issuable upon
      (i) exercise of the remaining, unexercised Warrants beneficially owned by
      the holder and its affiliates and (ii) exercise or conversion of the
      unexercised or unconverted portion of any other securities of the Company
      beneficially owned by the holder and its affiliates (including, without
      limitation, any convertible notes or preferred stock) subject to a limitation
      on
      conversion or exercise analogous to the limitation contained herein. Except
      as
      set forth in the preceding sentence, for purposes of this paragraph, beneficial
      ownership shall be calculated in accordance with Section 13(d) of the Securities
      Exchange Act of 1934, as amended. For purposes of this Warrant, in determining
      the number of outstanding shares of Common Stock a holder may rely on the number
      of outstanding shares of Common Stock as reflected in (1) the Company’s most
      recent Form 10-QSB or Form 10-KSB, as the case may be, (2) a more recent public
      announcement by the Company or (3) any other notice by the Company or its
      transfer agent setting forth the number of shares of Common Stock outstanding.
      Upon the written request of any holder, the Company shall promptly, but in
      no
      event later than one (1) Business Day following the receipt of such notice,
      confirm in writing to any such holder the number of shares of Common Stock
      then
      outstanding. In any case, the number of outstanding shares of Common Stock
      shall
      be determined after giving effect to the exercise of Warrants (as defined below)
      by such holder and its affiliates since the date as of which such number of
      outstanding shares of Common Stock was reported.

     

    
      
         

      

      
        1

        
          

        

      

      
         

      

    

     

    Section
      1.

     

    (a) This
      Warrant is the common stock purchase warrant (the “Warrant”)
      issued
      pursuant to the Securities Purchase Agreement (“Securities
      Purchase Agreement”)
      dated
      the date hereof between the Company and the Buyers listed on Schedule I
      thereto.

     

    (b) Definitions.
      The
      following words and terms as used in this Warrant shall have the following
      meanings:

     

    (i) “Approved
      Stock Plan”
means
      any employee benefit plan which has been approved by the Board of Directors
      of
      the Company, pursuant to which the Company’s securities may be issued to any
      employee, officer or director for services provided to the Company.

     

    (ii) “Business
      Day”
means
      any day other than Saturday, Sunday or other day on which commercial banks
      in
      the City of New York are authorized or required by law to remain
      closed.

     

    (iii) “Closing
      Bid Price”
means
      the closing bid price of Common Stock as quoted on the Principal Market (as
      reported by Bloomberg Financial Markets (“Bloomberg”)
      through its “Volume at Price” function).

     

    (iv) “Common
      Stock”
means
      (i) the Company’s common stock, par value $0.0001 per share, and
      (ii) any capital stock into which such Common Stock shall have been changed
      or any capital stock resulting from a reclassification of such Common
      Stock.

     

    (v) “Event
      of Default”
means
      an event of default under the Securities Purchase Agreement, the Convertible
      Debentures issued in connection therewith or the Investor’s Registration Rights
      Agreement dated the date hereof.

     

    (vi) “Excluded
      Securities”
means,
      provided such security is issued at a price which is greater than or equal
      to
      the arithmetic average of the Closing Bid Prices of the Common Stock for the
      ten
      (10) consecutive trading days immediately preceding the date of issuance, any
      of
      the following: (a) any issuance by the Company of securities in connection
      with
      a strategic partnership or a joint venture (the primary purpose of which is
      not
      to raise equity capital), (b) any issuance by the Company of securities as
      consideration for a merger or consolidation or the acquisition of a business,
      product, license, or other assets of another person or entity and (c) options
      to
      purchase shares of Common Stock, provided (I) such options are issued after
      the
      date of this Warrant to employees of the Company within thirty (30) days of
      such
      employee’s starting his employment with the Company, and (II) the exercise price
      of such options is not less than the Closing Bid Price of the Common Stock
      on
      the date of issuance of such option.

     

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

     

    (vii) “Expiration
      Date”
means
      the date five (5) years from the Issuance Date of this Warrant or, if such
      date
      falls on a Saturday, Sunday or other day on which banks are required or
      authorized to be closed in the City of New York or the State of New York or
      on
      which trading does not take place on the Principal Exchange or automated
      quotation system on which the Common Stock is traded (a “Holiday”),
      the
      next date that is not a Holiday.

     

    (viii) “Issuance
      Date”
means
      the date hereof.

     

    (ix) “Options”
means
      any rights, warrants or options to subscribe for or purchase Common Stock or
      Convertible Securities. 

     

    (x) “Other
      Securities”
means
      (i) those options and warrants of the Company issued prior to, and
      outstanding on, the Issuance Date of this Warrant, (ii) the shares of Common
      Stock issuable on exercise of such options and warrants, provided such options
      and warrants are not amended after the Issuance Date of this Warrant and
      (iii) the shares of Common Stock issuable upon exercise of this Warrant.

     

    (xi) “Person”
means
      an individual, a limited liability company, a partnership, a joint venture,
      a
      corporation, a trust, an unincorporated organization and a government or any
      department or agency thereof.

     

    (xii) “Principal
      Market”
means
      the New York Stock Exchange, the American Stock Exchange, the Nasdaq National
      Market, the Nasdaq SmallCap Market, whichever is at the time the principal
      trading exchange or market for such security, or the over-the-counter market
      on
      the electronic bulletin board for such security as reported by Bloomberg or,
      if
      no bid or sale information is reported for such security by Bloomberg, then
      the
      average of the bid prices of each of the market makers for such security as
      reported in the “pink sheets” by the National Quotation Bureau,
      Inc.

     

    (xiii) “Securities
      Act”
means
      the Securities Act of 1933, as amended. 

     

    (xiv) “Warrant”
means
      this Warrant and all Warrants issued in exchange, transfer or replacement
      thereof. 

     

    (xv) “Warrant
      Exercise Price”
shall
      be $0.02 or
      as
      subsequently adjusted as provided in Section 8 hereof. 

     

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

     

    (xvi) “Warrant
      Shares”
means
      the shares of Common Stock issuable at any time upon exercise of this Warrant.
      

     

    (c) Other
      Definitional Provisions. 

     

    (i) Except
      as
      otherwise specified herein, all references herein (A) to the Company shall
      be deemed to include the Company’s successors and (B) to any applicable law
      defined or referred to herein shall be deemed references to such applicable
      law
      as the same may have been or may be amended or supplemented from time to time.
      

     

    (ii) When
      used
      in this Warrant, the words “herein”,
      “hereof”,
      and
“hereunder”
      and
      words of similar import, shall refer to this Warrant as a whole and not to
      any
      provision of this Warrant, and the words “Section”,
      “Schedule”,
      and
“Exhibit”
shall
      refer to Sections of, and Schedules and Exhibits to, this Warrant unless
      otherwise specified. 

     

    (iii) Whenever
      the context so requires, the neuter gender includes the masculine or feminine,
      and the singular number includes the plural, and vice versa. 

     

    Section
      2. Exercise
      of Warrant.
      

     

    (a) Subject
      to the terms and conditions hereof, this Warrant may be exercised by the holder
      hereof then registered on the books of the Company, pro rata as hereinafter
      provided, at any time on any Business Day on or after the opening of business
      on
      such Business Day, commencing with the first day after the date hereof, and
      prior to 11:59 P.M. Eastern Time on the Expiration Date (i) by delivery of
      a written notice, in the form of the subscription notice attached as
Exhibit
      A
      hereto
      (the “Exercise
      Notice”),
      of
      such holder’s election to exercise this Warrant, which notice shall specify the
      number of Warrant Shares to be purchased, payment to the Company of an
      amount equal to the Warrant Exercise Price(s) applicable to the Warrant Shares
      being purchased, multiplied by the number of Warrant Shares (at the
      applicable Warrant Exercise Price) as to which this Warrant is being
      exercised (plus any applicable issue or transfer taxes) (the “Aggregate
      Exercise Price”)
      in
      cash or wire transfer of immediately available funds and the surrender of this
      Warrant (or an indemnification undertaking with respect to this Warrant in
      the
      case of its loss, theft or destruction) to a common carrier for overnight
      delivery to the Company as soon as practicable following such date
      (“Cash
      Basis”)
      or
      (ii) if at the time of exercise, the Warrant Shares are not subject to an
      effective registration statement or if an Event of Default has occurred, by
      delivering an Exercise Notice and in lieu of making payment of the Aggregate
      Exercise Price in cash or wire transfer, elect instead to receive upon such
      exercise the “Net Number” of shares of Common Stock determined according to the
      following formula (the “Cashless
      Exercise”):
      

     

    
      	
            	Net
              Number = 	
              (A
                x B) - (A x C)

            

    

    B

     

    For
      purposes of the foregoing formula: 

    

    A
      = the
      total number of Warrant Shares with respect to which this Warrant is then being
      exercised. 

    

    B
      = the
      Closing Bid Price of the Common Stock on the date of exercise of the
      Warrant.

    

    C
      = the
      Warrant Exercise Price then in effect for the applicable Warrant Shares at
      the
      time of such exercise. 

     

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

    

    In
      the
      event of any exercise of the rights represented by this Warrant in compliance
      with this Section 2, the Company shall on or before the fifth (5th)
      Business Day following the date of receipt of the Exercise Notice, the Aggregate
      Exercise Price and this Warrant (or an indemnification undertaking with respect
      to this Warrant in the case of its loss, theft or destruction) and the receipt
      of the representations of the holder specified in Section 6 hereof, if requested
      by the Company (the “Exercise
      Delivery Documents”),
      and
      if the Common Stock is DTC eligible, credit such aggregate number of shares
      of
      Common Stock to which the holder shall be entitled to the holder’s or its
      designee’s balance account with The Depository Trust Company; provided, however,
      if the holder who submitted the Exercise Notice requested physical delivery
      of
      any or all of the Warrant Shares, or, if the Common Stock is not DTC eligible
      then the Company shall, on or before the fifth (5th)
      Business Day following receipt of the Exercise Delivery Documents, issue and
      surrender to a common carrier for overnight delivery to the address specified
      in
      the Exercise Notice, a certificate, registered in the name of the holder, for
      the number of shares of Common Stock to which the holder shall be entitled
      pursuant to such request. Upon delivery of the Exercise Notice and Aggregate
      Exercise Price referred to in clause (i) or (ii) above the holder of this
      Warrant shall be deemed for all corporate purposes to have become the holder
      of
      record of the Warrant Shares with respect to which this Warrant has been
      exercised. In the case of a dispute as to the determination of the Warrant
      Exercise Price, the Closing Bid Price or the arithmetic calculation of the
      Warrant Shares, the Company shall promptly issue to the holder the number of
      Warrant Shares that is not disputed and shall submit the disputed determinations
      or arithmetic calculations to the holder via facsimile within one (1) Business
      Day of receipt of the holder’s Exercise Notice. 

     

    (b) If
      the
      holder and the Company are unable to agree upon the determination of the Warrant
      Exercise Price or arithmetic calculation of the Warrant Shares within one (1)
      day of such disputed determination or arithmetic calculation being submitted
      to
      the holder, then the Company shall immediately submit via facsimile (i) the
      disputed determination of the Warrant Exercise Price or the Closing Bid Price
      to
      an independent, reputable investment banking firm or (ii) the disputed
      arithmetic calculation of the Warrant Shares to its independent, outside
      accountant. The Company shall cause the investment banking firm or the
      accountant, as the case may be, to perform the determinations or calculations
      and notify the Company and the holder of the results no later than forty-eight
      (48) hours from the time it receives the disputed determinations or
      calculations. Such investment banking firm’s or accountant’s determination or
      calculation, as the case may be, shall be deemed conclusive absent manifest
      error.

     

    (c) Unless
      the rights represented by this Warrant shall have expired or shall have been
      fully exercised, the Company shall, as soon as practicable and in no event
      later
      than five (5) Business Days after any exercise and at its own expense, issue
      a
      new Warrant identical in all respects to this Warrant exercised except it shall
      represent rights to purchase the number of Warrant Shares purchasable
      immediately prior to such exercise under this Warrant exercised, less the number
      of Warrant Shares with respect to which such Warrant is exercised.

     

    
      
         

      

      
        5

        
          

        

      

      
         

      

    

     

    (d) No
      fractional Warrant Shares are to be issued upon any pro rata exercise of this
      Warrant, but rather the number of Warrant Shares issued upon such exercise
      of
      this Warrant shall be rounded up or down to the nearest whole
      number.

     

    (e) If
      the
      Company or its Transfer Agent shall fail for any reason or for no reason to
      issue to the holder within ten (10) days of receipt of the Exercise
      Delivery Documents, a certificate for the number of Warrant Shares to which
      the
      holder is entitled or to credit the holder’s balance account with The Depository
      Trust Company for such number of Warrant Shares to which the holder is entitled
      upon the holder’s exercise of this Warrant, the Company shall, in addition to
      any other remedies under this Warrant or the Placement Agent Agreement or
      otherwise available to such holder, pay as additional damages in cash to such
      holder on each day the issuance of such certificate for Warrant Shares is not
      timely effected an amount equal to 0.025% of the product of (A) the sum of
      the
      number of Warrant Shares not issued to the holder on a timely basis and to
      which
      the holder is entitled, and (B) the Closing Bid Price of the Common Stock for
      the trading day immediately preceding the last possible date which the Company
      could have issued such Common Stock to the holder without violating this
      Section 2.

     

    (f) If
      within
      ten (10) days after the Company’s receipt of the Exercise Delivery Documents,
      the Company fails to deliver a new Warrant to the holder for the number of
      Warrant Shares to which such holder is entitled pursuant to Section 2 hereof,
      then, in addition to any other available remedies under this Warrant, or
      otherwise available to such holder, the Company shall pay as additional damages
      in cash to such holder on each day after such tenth (10th)
      day
      that such delivery of such new Warrant is not timely effected in an amount
      equal
      to 0.25% of the product of (A) the number of Warrant Shares represented by
      the portion of this Warrant which is not being exercised and (B) the
      Closing Bid Price of the Common Stock for the trading day immediately preceding
      the last possible date which the Company could have issued such Warrant to
      the
      holder without violating this Section 2.

     

    Section
      3. Covenants
      as to Common Stock.
      The
      Company hereby covenants and agrees as follows:

     

    (a) This
      Warrant is, and any Warrants issued in substitution for or replacement of this
      Warrant will upon issuance be, duly authorized and validly issued.

     

    (b) All
      Warrant Shares which may be issued upon the exercise of the rights represented
      by this Warrant will, upon issuance, be validly issued, fully paid and
      nonassessable and free from all taxes, liens and charges with respect to the
      issue thereof.

     

    (c) During
      the period within which the rights represented by this Warrant may be exercised,
      the Company will at all times have authorized and reserved at least one hundred
      percent (100%) of the number of shares of Common Stock needed to provide for
      the
      exercise of the rights then represented by this Warrant and the par value of
      said shares will at all times be less than or equal to the applicable Warrant
      Exercise Price. If at any time the Company does not have a sufficient number
      of
      shares of Common Stock authorized and available, then the Company shall call
      and
      hold a special meeting of its stockholders within sixty (60) days of that
      time for the sole purpose of increasing the number of authorized shares of
      Common Stock.

     

    
      
         

      

      
        6

        
          

        

      

      
         

      

    

     

    (d) If
      at any
      time after the date hereof the Company shall file a registration statement,
      the
      Company shall include the Warrant Shares issuable to the holder, pursuant to
      the
      terms of this Warrant and shall maintain, so long as any other shares of Common
      Stock shall be so listed, such listing of all Warrant Shares from time to time
      issuable upon the exercise of this Warrant; and the Company shall so list on
      each national securities exchange or automated quotation system, as the case
      may
      be, and shall maintain such listing of, any other shares of capital stock of
      the
      Company issuable upon the exercise of this Warrant if and so long as any shares
      of the same class shall be listed on such national securities exchange or
      automated quotation system.

     

    (e) The
      Company will not, by amendment of its Articles of Incorporation or through
      any
      reorganization, transfer of assets, consolidation, merger, dissolution, issue
      or
      sale of securities, or any other voluntary action, avoid or seek to avoid the
      observance or performance of any of the terms to be observed or performed by
      it
      hereunder, but will at all times in good faith assist in the carrying out of
      all
      the provisions of this Warrant and in the taking of all such action as may
      reasonably be requested by the holder of this Warrant in order to protect the
      exercise privilege of the holder of this Warrant against dilution or other
      impairment, consistent with the tenor and purpose of this Warrant. The Company
      will not increase the par value of any shares of Common Stock receivable upon
      the exercise of this Warrant above the Warrant Exercise Price then in effect,
      and (ii) will take all such actions as may be necessary or appropriate in
      order that the Company may validly and legally issue fully paid and
      nonassessable shares of Common Stock upon the exercise of this
      Warrant.

     

    (f) This
      Warrant will be binding upon any entity succeeding to the Company by merger,
      consolidation or acquisition of all or substantially all of the Company’s
      assets.

     

    Section
      4. Taxes.
      The
      Company shall pay any and all taxes, except any applicable withholding, which
      may be payable with respect to the issuance and delivery of Warrant Shares
      upon
      exercise of this Warrant.

     

    Section
      5. Warrant
      Holder Not Deemed a Stockholder.
      Except
      as otherwise specifically provided herein, no holder, as such, of this Warrant
      shall be entitled to vote or receive dividends or be deemed the holder of shares
      of capital stock of the Company for any purpose, nor shall anything contained
      in
      this Warrant be construed to confer upon the holder hereof, as such, any of
      the
      rights of a stockholder of the Company or any right to vote, give or withhold
      consent to any corporate action (whether any reorganization, issue of stock,
      reclassification of stock, consolidation, merger, conveyance or otherwise),
      receive notice of meetings, receive dividends or subscription rights, or
      otherwise, prior to the issuance to the holder of this Warrant of the Warrant
      Shares which he or she is then entitled to receive upon the due exercise of
      this
      Warrant. In addition, nothing contained in this Warrant shall be construed
      as
      imposing any liabilities on such holder to purchase any securities (upon
      exercise of this Warrant or otherwise) or as a stockholder of the Company,
      whether such liabilities are asserted by the Company or by creditors of the
      Company. Notwithstanding this Section 5, the Company will provide the holder
      of
      this Warrant with copies of the same notices and other information given to
      the
      stockholders of the Company generally, contemporaneously with the giving thereof
      to the stockholders.

     

    
      
         

      

      
        7

        
          

        

      

      
         

      

    

     

    Section
      6. Representations
      of Holder.
      The
      holder of this Warrant, by the acceptance hereof, represents that it is
      acquiring this Warrant and the Warrant Shares for its own account for investment
      only and not with a view towards, or for resale in connection with, the public
      sale or distribution of this Warrant or the Warrant Shares, except pursuant
      to
      sales registered or exempted under the Securities Act; provided, however, that
      by making the representations herein, the holder does not agree to hold this
      Warrant or any of the Warrant Shares for any minimum or other specific term
      and
      reserves the right to dispose of this Warrant and the Warrant Shares at any
      time
      in accordance with or pursuant to a registration statement or an exemption
      under
      the Securities Act. The holder of this Warrant further represents, by acceptance
      hereof, that, as of this date, such holder is an “accredited investor” as such
      term is defined in Rule 501(a)(1) of Regulation D promulgated by the
      Securities and Exchange Commission under the Securities Act (an “Accredited
      Investor”).
      Upon
      exercise of this Warrant the holder shall, if requested by the Company, confirm
      in writing, in a form satisfactory to the Company, that the Warrant Shares
      so
      purchased are being acquired solely for the holder’s own account and not as a
      nominee for any other party, for investment, and not with a view toward
      distribution or resale and that such holder is an Accredited Investor. If such
      holder cannot make such representations because they would be factually
      incorrect, it shall be a condition to such holder’s exercise of this Warrant
      that the Company receive such other representations as the Company considers
      reasonably necessary to assure the Company that the issuance of its securities
      upon exercise of this Warrant shall not violate any United States or state
      securities laws.

     

    Section
      7. Ownership
      and Transfer.

     

    (a) The
      Company shall maintain at its principal executive offices (or such other office
      or agency of the Company as it may designate by notice to the holder hereof),
      a
      register for this Warrant, in which the Company shall record the name and
      address of the person in whose name this Warrant has been issued, as well as
      the
      name and address of each transferee. The Company may treat the person in whose
      name any Warrant is registered on the register as the owner and holder thereof
      for all purposes, notwithstanding any notice to the contrary, but in all events
      recognizing any transfers made in accordance with the terms of this
      Warrant.

     

    Section
      8. Adjustment
      of Warrant Exercise Price and Number of Shares.
      The
      Warrant Exercise Price and the number of shares of Common Stock issuable upon
      exercise of this Warrant shall be adjusted from time to time as
      follows:

     

    (a) Adjustment
      of Warrant Exercise Price and Number of Shares upon Issuance of Common
      Stock.
      If and
      whenever on or after the Issuance Date of this Warrant, the Company issues
      or
      sells, or is deemed to have issued or sold, any shares of Common
      Stock (other than (i) Excluded Securities, (ii) shares of Common Stock
      which are issued or deemed to have been issued by the Company in connection
      with
      an Approved Stock Plan, or (iii) the Other Securities) for a consideration
      per
      share less than a price (the “Applicable
      Price”)
      equal
      to the Warrant Exercise Price in effect immediately prior to such issuance
      or
      sale, then immediately after such issue or sale the Warrant Exercise Price
      then
      in effect shall be reduced to an amount equal to such consideration per share.
      Upon each such adjustment of the Warrant Exercise Price hereunder, the number
      of
      Warrant Shares issuable upon exercise of this Warrant shall be adjusted to
      the
      number of shares determined by multiplying the Warrant Exercise Price in effect
      immediately prior to such adjustment by the number of Warrant Shares issuable
      upon exercise of this Warrant immediately prior to such adjustment and dividing
      the product thereof by the Warrant Exercise Price resulting from such
      adjustment.

     

    
      
         

      

      
        8

        
          

        

      

      
         

      

    

     

    (b) Effect
      on Warrant Exercise Price of Certain Events.
      For
      purposes of determining the adjusted Warrant Exercise Price under Section 8(a)
      above, the following shall be applicable:

     

    (i) Issuance
      of Options.
      If
      after the date hereof, the Company in any manner grants any Options and the
      lowest price per share for which one share of Common Stock is issuable upon
      the
      exercise of any such Option or upon conversion or exchange of any convertible
      securities issuable upon exercise of any such Option is less than the Applicable
      Price, then such share of Common Stock shall be deemed to be outstanding and
      to
      have been issued and sold by the Company at the time of the granting or sale
      of
      such Option for such price per share. For purposes of this Section 8(b)(i),
      the
      lowest price per share for which one share of Common Stock is issuable upon
      exercise of such Options or upon conversion or exchange of such Convertible
      Securities shall be equal to the sum of the lowest amounts of consideration
      (if
      any) received or receivable by the Company with respect to any one share of
      Common Stock upon the granting or sale of the Option, upon exercise of the
      Option or upon conversion or exchange of any convertible security issuable
      upon
      exercise of such Option. No further adjustment of the Warrant Exercise Price
      shall be made upon the actual issuance of such Common Stock or of such
      convertible securities upon the exercise of such Options or upon the actual
      issuance of such Common Stock upon conversion or exchange of such convertible
      securities.

     

    (ii) Issuance
      of Convertible Securities.
      If the
      Company in any manner issues or sells any convertible securities and the lowest
      price per share for which one share of Common Stock is issuable upon the
      conversion or exchange thereof is less than the Applicable Price, then such
      share of Common Stock shall be deemed to be outstanding and to have been issued
      and sold by the Company at the time of the issuance or sale of such convertible
      securities for such price per share. For the purposes of this
      Section 8(b)(ii), the lowest price per share for which one share of Common
      Stock is issuable upon such conversion or exchange shall be equal to the sum
      of
      the lowest amounts of consideration (if any) received or receivable by the
      Company with respect to one share of Common Stock upon the issuance or sale
      of
      the convertible security and upon conversion or exchange of such convertible
      security. No further adjustment of the Warrant Exercise Price shall be made
      upon
      the actual issuance of such Common Stock upon conversion or exchange of such
      convertible securities, and if any such issue or sale of such convertible
      securities is made upon exercise of any Options for which adjustment of the
      Warrant Exercise Price had been or are to be made pursuant to other provisions
      of this Section 8(b), no further adjustment of the Warrant Exercise Price shall
      be made by reason of such issue or sale. 

     

    (iii) Change
      in Option Price or Rate of Conversion.
      If the
      purchase price provided for in any Options, the additional consideration, if
      any, payable upon the issue, conversion or exchange of any convertible
      securities, or the rate at which any convertible securities are convertible
      into
      or exchangeable for Common Stock changes at any time, the Warrant Exercise
      Price
      in effect at the time of such change shall be adjusted to the Warrant Exercise
      Price which would have been in effect at such time had such Options or
      convertible securities provided for such changed purchase price, additional
      consideration or changed conversion rate, as the case may be, at the time
      initially granted, issued or sold and the number of Warrant Shares issuable
      upon
      exercise of this Warrant shall be correspondingly readjusted. For purposes
      of
      this Section 8(b)(iii), if the terms of any Option or convertible security
      that
      was outstanding as of the Issuance Date of this Warrant are changed in the
      manner described in the immediately preceding sentence, then such Option or
      convertible security and the Common Stock deemed issuable upon exercise,
      conversion or exchange thereof shall be deemed to have been issued as of the
      date of such change. No adjustment pursuant to this Section 8(b) shall be
      made if such adjustment would result in an increase of the Warrant Exercise
      Price then in effect.

     

    
      
         

      

      
        9

        
          

        

      

      
         

      

    

     

    (c) Effect
      on Warrant Exercise Price of Certain Events.
      For
      purposes of determining the adjusted Warrant Exercise Price under
      Sections 8(a) and 8(b), the following shall be applicable:

     

    (i) Calculation
      of Consideration Received.
      If any
      Common Stock, Options or convertible securities are issued or sold or deemed
      to
      have been issued or sold for cash, the consideration received therefore will
      be
      deemed to be the net amount received by the Company therefore. If any Common
      Stock, Options or convertible securities are issued or sold for a consideration
      other than cash, the amount of such consideration received by the Company will
      be the fair value of such consideration, except where such consideration
      consists of marketable securities, in which case the amount of consideration
      received by the Company will be the market price of such securities on the
      date
      of receipt of such securities. If any Common Stock, Options or convertible
      securities are issued to the owners of the non-surviving entity in connection
      with any merger in which the Company is the surviving entity, the amount of
      consideration therefore will be deemed to be the fair value of such portion
      of
      the net assets and business of the non-surviving entity as is attributable
      to
      such Common Stock, Options or convertible securities, as the case may be. The
      fair value of any consideration other than cash or securities will be determined
      jointly by the Company and the holders of Warrants representing at least
      two-thirds (b) of the Warrant Shares issuable upon exercise of the Warrants
      then
      outstanding. If such parties are unable to reach agreement within ten (10)
      days after the occurrence of an event requiring valuation (the “Valuation
      Event”),
      the
      fair value of such consideration will be determined within five (5) Business
      Days after the tenth (10th)
      day
      following the Valuation Event by an independent, reputable appraiser jointly
      selected by the Company and the holders of Warrants representing at least
      two-thirds (b) of the Warrant Shares issuable upon exercise of the Warrants
      then
      outstanding. The determination of such appraiser shall be final and binding
      upon
      all parties and the fees and expenses of such appraiser shall be borne jointly
      by the Company and the holders of Warrants.

     

    (ii) Integrated
      Transactions.
      In case
      any Option is issued in connection with the issue or sale of other securities
      of
      the Company, together comprising one integrated transaction in which no specific
      consideration is allocated to such Options by the parties thereto, the Options
      will be deemed to have been issued for a consideration of $.01.

     

    (iii) Treasury
      Shares.
      The
      number of shares of Common Stock outstanding at any given time does not include
      shares owned or held by or for the account of the Company, and the disposition
      of any shares so owned or held will be considered an issue or sale of Common
      Stock.

     

    
      
         

      

      
        10

        
          

        

      

      
         

      

    

     

    (iv) Record
      Date.
      If the
      Company takes a record of the holders of Common Stock for the purpose of
      entitling them (1) to receive a dividend or other distribution payable in
      Common Stock, Options or in convertible securities or (2) to subscribe for
      or purchase Common Stock, Options or convertible securities, then such record
      date will be deemed to be the date of the issue or sale of the shares of Common
      Stock deemed to have been issued or sold upon the declaration of such dividend
      or the making of such other distribution or the date of the granting of such
      right of subscription or purchase, as the case may be.

     

    (d) Adjustment
      of Warrant Exercise Price upon Subdivision or Combination of Common
      Stock.
      If the
      Company at any time after the date of issuance of this Warrant subdivides (by
      any stock split, stock dividend, recapitalization or otherwise) one or more
      classes of its outstanding shares of Common Stock into a greater number of
      shares, any Warrant Exercise Price in effect immediately prior to such
      subdivision will be proportionately reduced and the number of shares of Common
      Stock obtainable upon exercise of this Warrant will be proportionately
      increased. If the Company at any time after the date of issuance of this Warrant
      combines (by combination, reverse stock split or otherwise) one or more classes
      of its outstanding shares of Common Stock into a smaller number of shares,
      any
      Warrant Exercise Price in effect immediately prior to such combination will
      be
      proportionately increased and the number of Warrant Shares issuable upon
      exercise of this Warrant will be proportionately decreased. Any adjustment
      under
      this Section 8(d) shall become effective at the close of business on the
      date the subdivision or combination becomes effective.

     

    (e) Distribution
      of Assets.
      If the
      Company shall declare or make any dividend or other distribution of its assets
      (or rights to acquire its assets) to holders of Common Stock, by way of return
      of capital or otherwise (including, without limitation, any distribution of
      cash, stock or other securities, property or options by way of a dividend,
      spin
      off, reclassification, corporate rearrangement or other similar transaction)
      (a
“Distribution”),
      at
      any time after the issuance of this Warrant, then, in each such
      case:

     

    (i) any
      Warrant Exercise Price in effect immediately prior to the close of business
      on
      the record date fixed for the determination of holders of Common Stock
      entitled to
      receive the Distribution shall be reduced, effective as of the close of business
      on such record date, to a price determined by multiplying such Warrant Exercise
      Price by a fraction of which (A) the numerator shall be the Closing Sale Price
      of the Common Stock on the trading day immediately preceding such record date
      minus the value of the Distribution (as determined in good faith by the
      Company’s Board of Directors) applicable to one share of Common Stock, and (B)
      the denominator shall be the Closing Sale Price of the Common Stock on the
      trading day immediately preceding such record date; and

     

    (ii) either
      (A) the number of Warrant Shares obtainable upon exercise of this Warrant shall
      be increased to a number of shares equal to the number of shares of Common
      Stock
      obtainable immediately prior to the close of business on the record date fixed
      for the determination of holders of Common Stock entitled to receive the
      Distribution multiplied by the reciprocal of the fraction set forth in the
      immediately preceding clause (i), or (B) in the event that the Distribution
      is
      of common stock of a company whose common stock is traded on a national
      securities exchange or a national automated quotation system, then the holder
      of
      this Warrant shall receive an additional warrant to purchase Common Stock,
      the
      terms of which shall be identical to those of this Warrant, except that such
      warrant shall be exercisable into the amount of the assets that would have
      been
      payable to the holder of this Warrant pursuant to the Distribution had the
      holder exercised this Warrant immediately prior to such record date and with
      an
      exercise price equal to the amount by which the exercise price of this Warrant
      was decreased with respect to the Distribution pursuant to the terms of the
      immediately preceding clause (i).

     

    
      
         

      

      
        11

        
          

        

      

      
         

      

    

     

    (f) Certain
      Events.
      If any
      event occurs of the type contemplated by the provisions of this Section 8
      but not expressly provided for by such provisions (including, without
      limitation, the granting of stock appreciation rights, phantom stock rights
      or
      other rights with equity features), then the Company’s Board of Directors will
      make an appropriate adjustment in the Warrant Exercise Price and the number
      of
      shares of Common Stock obtainable upon exercise of this Warrant so as to protect
      the rights of the holders of the Warrants; provided, except as set forth in
      section 8(d),that no such adjustment pursuant to this Section 8(f) will increase
      the Warrant Exercise Price or decrease the number of shares of Common Stock
      obtainable as otherwise determined pursuant to this Section 8.

     

    (g) Notices.

     

    (i) Immediately
      upon any adjustment of the Warrant Exercise Price, the Company will give written
      notice thereof to the holder of this Warrant, setting forth in reasonable
      detail, and certifying, the calculation of such adjustment.

     

    (ii) The
      Company will give written notice to the holder of this Warrant at least ten
      (10)
      days prior to the date on which the Company closes its books or takes a record
      (A) with respect to any dividend or distribution upon the Common Stock,
      (B) with respect to any pro rata subscription offer to holders of Common
      Stock or (C) for determining rights to vote with respect to any Organic
      Change (as defined below), dissolution or liquidation, provided that such
      information shall be made known to the public prior to or in conjunction with
      such notice being provided to such holder.

     

    (iii) The
      Company will also give written notice to the holder of this Warrant at least
      ten
      (10) days prior to the date on which any Organic Change, dissolution or
      liquidation will take place, provided that such information shall be made known
      to the public prior to or in conjunction with such notice being provided to
      such
      holder.

     

    Section
      9. Purchase
      Rights; Reorganization, Reclassification, Consolidation, Merger or
      Sale.

     

    (a) In
      addition to any adjustments pursuant to Section 8 above, if at any time the
      Company grants, issues or sells any Options, Convertible Securities or rights
      to
      purchase stock, warrants, securities or other property pro rata to the record
      holders of any class of Common Stock (the “Purchase
      Rights”),
      then
      the holder of this Warrant will be entitled to acquire, upon the terms
      applicable to such Purchase Rights, the aggregate Purchase Rights which such
      holder could have acquired if such holder had held the number of shares of
      Common Stock acquirable upon complete exercise of this Warrant immediately
      before the date on which a record is taken for the grant, issuance or sale
      of
      such Purchase Rights, or, if no such record is taken, the date as of which
      the
      record holders of Common Stock are to be determined for the grant, issue or
      sale
      of such Purchase Rights.

     

    
      
         

      

      
        12

        
          

        

      

      
         

      

    

     

    (b) Any
      recapitalization, reorganization, reclassification, consolidation, merger,
      sale
      of all or substantially all of the Company’s assets to another Person or other
      transaction in each case which is effected in such a way that holders of Common
      Stock are entitled to receive (either directly or upon subsequent liquidation)
      stock, securities or assets with respect to or in exchange for Common Stock
      is
      referred to herein as an “Organic
      Change.”
Prior
      to the consummation of any (i) sale of all or substantially all of the Company’s
      assets to an acquiring Person or (ii) other Organic Change following which
      the
      Company is not a surviving entity, the Company will secure from the Person
      purchasing such assets or the successor resulting from such Organic Change
      (in
      each case, the “Acquiring
      Entity”)
      a
      written agreement (in form and substance satisfactory to the holders of Warrants
      representing at least two-thirds (iii) of the Warrant Shares issuable upon
      exercise of the Warrants then outstanding) to deliver to each holder of Warrants
      in exchange for such Warrants, a security of the Acquiring Entity evidenced
      by a
      written instrument substantially similar in form and substance to this Warrant
      and satisfactory to the holders of the Warrants (including an adjusted warrant
      exercise price equal to the value for the Common Stock reflected by the terms
      of
      such consolidation, merger or sale, and exercisable for a corresponding number
      of shares of Common Stock acquirable and receivable upon exercise of the
      Warrants without regard to any limitations on exercise, if the value so
      reflected is less than any Applicable Warrant Exercise Price immediately prior
      to such consolidation, merger or sale). Prior to the consummation of any other
      Organic Change, the Company shall make appropriate provision (in form and
      substance satisfactory to the holders of Warrants representing a
      majority of
      the
      Warrant Shares issuable upon exercise of the Warrants then outstanding) to
      insure that each of the holders of the Warrants will thereafter have the right
      to acquire and receive in lieu of or in addition to (as the case may be) the
      Warrant Shares immediately theretofore issuable and receivable upon the exercise
      of such holder’s Warrants (without regard to any limitations on exercise),
      such shares of stock, securities or assets that would have been issued or
      payable in such Organic Change with respect to or in exchange for the number
      of
      Warrant Shares which would have been issuable and receivable upon the exercise
      of such holder’s Warrant as of the date of such Organic Change (without taking
      into account any limitations or restrictions on the exercisability of this
      Warrant).

     

    Section
      10. Lost,
      Stolen, Mutilated or Destroyed Warrant.
      If this
      Warrant is lost, stolen, mutilated or destroyed, the Company shall promptly,
      on
      receipt of an indemnification undertaking (or, in the case of a mutilated
      Warrant, the Warrant), issue a new Warrant of like denomination and tenor as
      this Warrant so lost, stolen, mutilated or destroyed.

     

    Section
      11. Notice.
      Any
      notices, consents, waivers or other communications required or permitted to
      be
      given under the terms of this Warrant must be in writing and will be deemed
      to
      have been delivered: (i) upon receipt, when delivered personally;
      (ii) upon receipt, when sent by facsimile (provided confirmation of receipt
      is received by the sending party transmission is mechanically or electronically
      generated and kept on file by the sending party); or (iii) one Business Day
      after deposit with a nationally recognized overnight delivery service, in each
      case properly addressed to the party to receive the same. The addresses and
      facsimile numbers for such communications shall be:

     

    
      
         

      

      
        13

        
          

        

      

      
         

      

    

     

    
      	
              If
                to Holder:

            	
              Cornell
                Capital Partners, LP

            
	 	
              101
                Hudson Street - Suite 3700

            
	 	
              Jersey
                City, NJ 07302

            
	 	
              Attention: Mark
                A. Angelo

            
	 	
              Telephone: (201)
                985-8300

            
	 	
              Facsimile:  (201)
                985-8266

            
	 	 
	
              With
                Copy to:

            	
              David
                Gonzalez, Esq.

            
	 	
              101
                Hudson Street - Suite 3700

            
	 	
              Jersey
                City, NJ 07302

            
	 	
              Telephone: (201)
                985-8300

            
	 	
              Facsimile: (201)
                985-8266

            
	 	 
	
              If
                to the Company, to:

            	
              Pacer
                Health Corporation

            
	 	
              7759
                N.W. 146th
                Street

            
	 	
              Miami
                Lakes, Florida 33016

            
	 	
              Attention: Rainier
                Gonzalez

            
	 	
              Telephone: (305)
                828-7660

            
	 	
              Facsimile: (305)
                282-2551

            
	 	 
	
              With
                a copy to:

            	
              Kirkpatrick
                & Lockhart Nicholson Graham, LLP

            
	 	
              201
                South Biscayne Boulevard, Suite 2000

            
	 	
              Miami,
                Florida 33131

            
	 	
              Attention: Clayton
                E. Parker, Esquire

            
	 	
              Telephone: (305)
                539-3306 

            
	 	
              Facsimile: (305)
                358-7095 

            

    

    

    If
      to a
      holder of this Warrant, to it at the address and facsimile number set forth
      on
Exhibit C
      hereto,
      with copies to such holder’s representatives as set forth on Exhibit C,
      or at
      such other address and facsimile as shall be delivered to the Company upon
      the
      issuance or transfer of this Warrant. Each party shall provide five days’ prior
      written notice to the other party of any change in address or facsimile number.
      Written confirmation of receipt (A) given by the recipient of such notice,
      consent, facsimile, waiver or other communication, (or (B) provided by a
      nationally recognized overnight delivery service shall be rebuttable evidence
      of
      personal service, receipt by facsimile or receipt from a nationally recognized
      overnight delivery service in accordance with clause (i), (ii) or (iii) above,
      respectively.

     

    Section
      12. Date.
      The
      date of this Warrant is set forth on page 1 hereof. This Warrant, in all
      events, shall be wholly void and of no effect after the close of business on
      the
      Expiration Date, except that notwithstanding any other provisions hereof, the
      provisions of Section 8(b) shall continue in full force and effect after
      such date as to any Warrant Shares or other securities issued upon the exercise
      of this Warrant.

     

    
      
         

      

      
        14

        
          

        

      

      
         

      

    

     

    Section
      13. Amendment
      and Waiver.
      Except
      as otherwise provided herein, the provisions of the Warrants may be amended
      and
      the Company may take any action herein prohibited, or omit to perform any act
      herein required to be performed by it, only if the Company has obtained the
      written consent of the holders of Warrants representing at least two-thirds
      of
      the Warrant Shares issuable upon exercise of the Warrants then outstanding;
      provided that, except for Section 8(d), no such action may increase the Warrant
      Exercise Price or decrease the number of shares or class of stock obtainable
      upon exercise of any Warrant without the written consent of the holder of such
      Warrant.

     

    Section
      14. Descriptive
      Headings; Governing Law.
      The
      descriptive headings of the several sections and paragraphs of this Warrant
      are
      inserted for convenience only and do not constitute a part of this Warrant.
      The
      corporate laws of the State of Florida shall govern all issues concerning the
      relative rights of the Company and its stockholders. All other questions
      concerning the construction, validity, enforcement and interpretation of this
      Agreement shall be governed by the internal laws of the State of New Jersey,
      without giving effect to any choice of law or conflict of law provision or
      rule
      (whether of the State of New Jersey or any other jurisdictions) that would
      cause
      the application of the laws of any jurisdictions other than the State of New
      Jersey. Each party hereby irrevocably submits to the exclusive jurisdiction
      of
      the state and federal courts sitting in Hudson County and the United States
      District Court for the District of New Jersey, for the adjudication of any
      dispute hereunder or in connection herewith or therewith, or with any
      transaction contemplated hereby or discussed herein, and hereby irrevocably
      waives, and agrees not to assert in any suit, action or proceeding, any claim
      that it is not personally subject to the jurisdiction of any such court, that
      such suit, action or proceeding is brought in an inconvenient forum or that
      the
      venue of such suit, action or proceeding is improper. Each party hereby
      irrevocably waives personal service of process and consents to process being
      served in any such suit, action or proceeding by mailing a copy thereof to
      such
      party at the address for such notices to it under this Agreement and agrees
      that
      such service shall constitute good and sufficient service of process and notice
      thereof. Nothing contained herein shall be deemed to limit in any way any right
      to serve process in any manner permitted by law. 

     

    Section
      15. Waiver
      of Jury Trial.
      AS
      A MATERIAL INDUCEMENT FOR EACH PARTY HERETO TO ENTER INTO THIS WARRANT, THE
      PARTIES HERETO HEREBY WAIVE ANY RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING
      RELATED IN ANY WAY TO THIS WARRANT AND/OR ANY AND ALL OF THE OTHER DOCUMENTS
      ASSOCIATED WITH THIS TRANSACTION.

     

    

    [REMAINDER
      OF PAGE INTENTIONALLY LEFT BLANK]

     

     

    
      
         

      

      
        15

        
          

        

      

      
         

      

    

     

    IN
      WITNESS WHEREOF,
      the
      Company has caused this Warrant to be signed as of the date first set forth
      above.

     

    
      	 	
              PACER
                HEALTH CORPORATION

            
	 	 
	 	
              By:_______________________________      

            
	 	
              Name: Rainier
                Gonzalez

            
	 	
              Title: CEO

            

    

     

    

     

    
      
         

      

      
        16

        
          

        

      

      
         

      

    

    EXHIBIT
      A TO WARRANT

     

    EXERCISE
      NOTICE

     

    TO
      BE EXECUTED 

    BY
      THE REGISTERED HOLDER TO EXERCISE THIS WARRANT

     

    PACER
      HEALTH CORPORATION

     

    The
      undersigned holder hereby exercises the right to purchase ______________ of
      the
      shares of Common Stock (“Warrant
      Shares”)
      of
      Pacer Health Corporation (the “Company”),
      evidenced by the attached Warrant (the “Warrant”).
      Capitalized terms used herein and not otherwise defined shall have the
      respective meanings set forth in the Warrant.

     

    Specify
      Method of exercise by check mark:

     

    1.
      ___ Cash
      Exercise

     

    (a)
      Payment
      of Warrant Exercise Price.
      The
      holder shall pay the Aggregate Exercise Price of $______________ to the Company
      in accordance with the terms of the Warrant. 

     

    (b)
      Delivery
      of Warrant Shares.
      The
      Company shall deliver to the holder _________
      Warrant
      Shares in accordance with the terms of the Warrant. 

     

    

     

    2.
      ___ Cashless
      Exercise

     

    (a)
      Payment
      of Warrant Exercise Price.
      In lieu
      of making payment of the Aggregate Exercise Price, the holder elects to receive
      upon such exercise the Net Number of shares of Common Stock determined in
      accordance with the terms of the Warrant. 

     

    (b)
      Delivery
      of Warrant Shares.
      The
      Company shall deliver to the holder _________
      Warrant
      Shares in accordance with the terms of the Warrant. 

     

    

    Date:
      _______________ __, ______

    

    Name
      of
      Registered Holder

    

    By:     

    Name:     

    Title:     

    

     

    

 

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

     

    EXHIBIT
      B TO WARRANT

     

    FORM
      OF WARRANT POWER

     

    FOR
      VALUE RECEIVED,
      the
      undersigned does hereby assign and transfer to ________________, Federal
      Identification No. __________, a warrant to purchase ____________ shares of
      the capital stock of Pacer Health Corporation represented by warrant certificate
      no. _____, standing in the name of the undersigned on the books of said
      corporation. The undersigned does hereby irrevocably constitute and appoint
      ______________, attorney to transfer the warrants of said corporation, with
      full
      power of substitution in the premises.

     

    
      	
              Dated:______________________________________________________________

            	 _______________________________________________________________
	 	 
	 	
              By:______________________________________________________________________

            
	 	
              Name:____________________________________________________________________

            
	 	
              Title:_____________________________________________________________________

            
	 	 

    

    

    

    

    
       

      
        
           

        

        
          B-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00101-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00101-of-00352.parquet"}]]